COMPANY

PAQ Therapeutics

HQ: Burlington, MA source · paqtx.com ↗

Location: Burlington, MA · source · Oct 14, 2026

Profile checked Oct 10, 2026

Keywords: Colorectal Cancer Pancreatic Cancer Non-Small Cell Lung Cancer PT0253 PT0511

Timeline

Nov 21, 2025 Trial start Phase 1: A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors source ↗
Dec 19, 2024 Trial start Phase 1: A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors source ↗

Dec 15, 2026 (ESTIMATED) · Phase 1 · A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors · NCT06797336
Oct 18, 2028 (ESTIMATED) · Phase 1 · A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors · NCT07300150

Estimated primary completion per ClinicalTrials.gov. Dates move.

Record	Title	Phase	Status	Start	Primary completion
NCT06797336	A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors	Phase 1	Recruiting	Dec 19, 2024	Dec 15, 2026 (estimated)
NCT07300150	A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors	Phase 1	Recruiting	Nov 21, 2025	Oct 18, 2028 (estimated)